Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Lidocaine Infiltration to See If It Helps Inflammation and Brain Function After Head and Neck Cancer Surgery

Official title: Lidocaine and Neuroimmunomodulation: The Effect of Local Anesthetic Concentration in Head and Neck Cancer Resections

Run by University Medical Centre Ljubljana · NCT07922759 · Data updated 2026-11-12

This study tests whether different amounts of lidocaine injected into the surgical area can influence inflammation and brain-related outcomes after major head and neck cancer surgery in adults.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorUniversity Medical Centre Ljubljana
Academic / other
Locations1 site (Ljubljana)
StatusRecruiting
StartedJune 20, 2026
Main results expectedJune 2028
Study endsDecember 2028
Registry record updatedNovember 6, 2026
Trial IDNCT07922759 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older undergoing oncological head and neck resection with microvascular free-flap reconstruction at the University Medical Centre Ljubljana.

Probably not a fit

Patients with certain comorbidities or baseline conditions may not experience measurable cognitive or inflammatory benefits from lidocaine infiltration.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized pilot trial in adults undergoing oncological head and neck resection with microvascular free-flap reconstruction. Participants are assigned to receive either 150 mg or 300 mg of lidocaine infiltrated in the surgical field at the start of surgery, to explore effects on perioperative inflammation, neuronal/glial injury biomarkers, and postoperative cognitive function. The study uses a prospective design to compare dose-related biological and neurocognitive responses in a single-center setting at University Medical Centre Ljubljana. Outcomes will inform whether local lidocaine infiltration at different doses modulates systemic stress and neuroinflammatory processes after major head and neck cancer procedures. No results are provided yet as this is an initial pilot to assess feasibility and signal of effect.

Why it matters

Potential benefit: If successful, the approach could reduce postoperative inflammation and protect brain function after complex head and neck cancer surgery.

How similar studies have gone: Prior perioperative lidocaine studies often focus on intravenous administration; evidence for local infiltration dose effects on neuroinflammation and cognition is limited but exploratory data exist.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients aged 18 years or older.
* Patients scheduled for oncological resection of head and neck cancer followed by microvascular soft-tissue free-flap reconstruction.
* Body mass index (BMI) \< 30 kg/m².
* No known hypersensitivity to amide-type local anesthetics or components of the infiltration solutions.
* Ability and willingness to provide written informed consent for participation in the study.

Exclusion Criteria:

* Refusal to participate or inability to provide written informed consent.
* Known hypersensitivity to lidocaine or any component of the infiltration solution.
* Heart failure with a left ventricular ejection fraction \< 50%.
* Cardiac conduction disorders without an implanted pacemaker.
* Uncontrolled epilepsy.
* Hepatic or renal insufficiency.
* Pregnancy or breastfeeding.
* Pre-existing neurological diseases.
* Psychiatric disorders.
* Preoperative Mini-Mental State Examination (MMSE) score \< 23 points.

Where it's running

  • University Medical Centre Ljubljana
    Ljubljana, Slovenia
    Recruiting

Study contacts

  • Principal investigator: Liljana Markova, MD, PhD — University Medical Centre Ljubljana
  • Study coordinator: Liljana Markova, MD, PhD
  • Email: liljana.markova@kclj.si
  • Phone: +38640802662

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.